-
IntroducedFeb 18, 2025
-
Passed House
-
Passed Senate
-
Signed into Law
To direct the Comptroller General of the United States to conduct a study to assess the key regulatory barriers that impede the expansion or siting of new pharmaceutical manufacturing facilities in the United States, and for other purposes.
Last Action See all actions
House • Feb 18, 2025: Referred to the House Committee on Energy and Commerce.
Summary/Bill Text
Comments on HR 1405
Tweets
Whip Lists
Sponsors
Votes
Actions
- Feb 18, 2025 | House
- Introduced in House
- Referred to the House Committee on Energy and Commerce.
Bill Texts
Documents